PULSE BIOSCIENCES, INC. — Director's Dealing 2025

Feb 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2025-01-24

Reporting Person: Zanganeh Mahkam (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-24	Common Stock	X	30121	$11	Acquired	695274	Direct
2025-02-03	Common Stock	X	30121	$11	Acquired	725395	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-24	Warrant (right to buy)	$11	X	30121	Disposed	2029-07-03	Common Stock (30121)	Direct
2025-02-03	Warrant (right to buy)	$11	X	30121	Disposed	2029-07-03	Common Stock (30121)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	27000	Indirect
Common Stock	14000	Indirect
Common Stock	107074	Indirect